DDX53 and neoplasm: Mice bearing subcutaneous flank tumours (TRAMPC1, CT26 and RENCA) were administered PBS, MG-Empty or MG-TNFα i.t (TRAMP, RENCA) or i.v. (CT26) and tumour volume and survival monitored over time (Fig 5).